Hollsteen
← F5

D&A

Flow – sum over the period · $M

QuartersFiscal years

$MD&A · Q1 FY2016: $14.0M · 10-Q 0001048695-16-000026 filed Jan 27, 2016D&A · Q2 FY2016: $14.0M · derived · 10-Q 0001048695-17-000016 filed May 10, 2017D&A · Q3 FY2016: $14.0M · derived · 10-Q 0001048695-17-000022 filed Aug 2, 2017D&A · Q4 FY2016: $14.0M · derived · 10-K 0001048695-17-000028 filed Nov 3, 2017D&A · Q1 FY2017: $15.0M · 10-Q 0001048695-17-000008 filed Feb 1, 2017D&A · Q2 FY2017: $15.0M · derived · 10-Q 0001048695-18-000017 filed May 2, 2018D&A · Q3 FY2017: $15.0M · derived · 10-Q 0001048695-18-000025 filed Aug 1, 2018D&A · Q4 FY2017: $16.0M · derived · 10-K 0001048695-18-000031 filed Nov 21, 2018D&A · Q1 FY2018: $15.0M · 10-Q 0001048695-18-000005 filed Feb 2, 2018D&A · Q2 FY2018: $15.0M · derived · 10-Q 0001048695-19-000014 filed May 3, 2019D&A · Q3 FY2018: $14.0M · derived · 10-Q 0001048695-19-000030 filed Aug 2, 2019D&A · Q4 FY2018: $15.0M · derived · 10-K 0001048695-19-000034 filed Nov 15, 2019D&A · Q1 FY2019: $14.0M · 10-Q 0001048695-19-000008 filed Feb 1, 2019D&A · Q2 FY2019: $14.0M · derived · 10-Q 0001048695-20-000027 filed May 6, 2020D&A · Q3 FY2019: $18.0M · derived · 10-Q 0001048695-20-000035 filed Aug 5, 2020D&A · Q4 FY2019: $22.0M · derived · 10-K 0001048695-20-000041 filed Nov 19, 2020D&A · Q1 FY2020: $19.0M · 10-Q 0001048695-20-000012 filed Feb 5, 2020D&A · Q2 FY2020: $24.0M · derived · 10-Q 0001048695-21-000021 filed May 6, 2021D&A · Q3 FY2020: $26.0M · derived · 10-Q 0001048695-21-000033 filed Aug 5, 2021D&A · Q4 FY2020: $27.0M · derived · 10-K 0001048695-21-000044 filed Nov 16, 2021D&A · Q1 FY2021: $28.0M · 10-Q 0001048695-21-000009 filed Feb 5, 2021D&A · Q2 FY2021: $29.0M · derived · 10-Q 0001048695-22-000015 filed May 6, 2022D&A · Q3 FY2021: $29.0M · derived · 10-Q 0001048695-22-000025 filed Aug 5, 2022D&A · Q4 FY2021: $30.0M · derived · 10-K 0001048695-22-000033 filed Nov 15, 2022D&A · Q1 FY2022: $30.0M · 10-Q 0001048695-22-000007 filed Feb 4, 2022D&A · Q2 FY2022: $30.0M · derived · 10-Q 0001048695-23-000018 filed May 5, 2023D&A · Q3 FY2022: $29.0M · derived · 10-Q 0001048695-23-000030 filed Aug 4, 2023D&A · Q4 FY2022: $27.0M · derived · 10-K 0001048695-23-000039 filed Nov 14, 2023D&A · Q1 FY2023: $27.0M · 10-Q 0001048695-23-000011 filed Feb 3, 2023D&A · Q2 FY2023: $27.0M · derived · 10-Q 0001048695-24-000079 filed May 6, 2024D&A · Q3 FY2023: $28.0M · derived · 10-Q 0001048695-24-000125 filed Aug 6, 2024D&A · Q4 FY2023: $30.0M · derived · 10-K 0001048695-24-000185 filed Nov 18, 2024D&A · Q1 FY2024: $29.0M · 10-Q 0001048695-24-000012 filed Feb 5, 2024D&A · Q2 FY2024: $28.0M · derived · 10-Q 0001048695-25-000091 filed May 6, 2025D&A · Q3 FY2024: $27.0M · derived · 10-Q 0001048695-25-000129 filed Aug 6, 2025D&A · Q4 FY2024: $23.0M · derived · 10-K 0001048695-25-000157 filed Nov 25, 2025D&A · Q1 FY2025: $23.0M · 10-Q 0001048695-25-000026 filed Feb 7, 2025D&A · Q2 FY2025: $22.0M · derived · 10-Q 0001048695-26-000051 filed May 5, 2026D&A · Q3 FY2025: $22.0M · derived · 10-Q 0001048695-26-000067 filed Aug 6, 2026D&A · Q4 FY2025: $25.0M · derived · 10-K 0001048695-25-000157 filed Nov 25, 2025D&A · Q1 FY2026: $25.0M · 10-Q 0001048695-26-000023 filed Feb 5, 2026D&A · Q2 FY2026: $25.0M · derived · 10-Q 0001048695-26-000051 filed May 5, 2026D&A · Q3 FY2026: $23.0M · derived · 10-Q 0001048695-26-000067 filed Aug 6, 202629.5a23.4a13.8Q1 FY2016Q3 FY2026Q2 FY2022
$MD&A · Q2 FY2021: $29.0M · derived · 10-Q 0001048695-22-000015 filed May 6, 2022D&A · Q3 FY2021: $29.0M · derived · 10-Q 0001048695-22-000025 filed Aug 5, 2022D&A · Q4 FY2021: $30.0M · derived · 10-K 0001048695-22-000033 filed Nov 15, 2022D&A · Q1 FY2022: $30.0M · 10-Q 0001048695-22-000007 filed Feb 4, 2022D&A · Q2 FY2022: $30.0M · derived · 10-Q 0001048695-23-000018 filed May 5, 2023D&A · Q3 FY2022: $29.0M · derived · 10-Q 0001048695-23-000030 filed Aug 4, 2023D&A · Q4 FY2022: $27.0M · derived · 10-K 0001048695-23-000039 filed Nov 14, 2023D&A · Q1 FY2023: $27.0M · 10-Q 0001048695-23-000011 filed Feb 3, 202329.5a27.528.5a30.4aQ2 FY2021Q1 FY2023Q2 FY2022
Q2 FY2022
29.5a$M
derived
All values (43)
PeriodValue ($M)Status
Q3 FY202623.4derived
Q2 FY202624.6derived
Q1 FY202624.6reported
Q4 FY202524.8derived
Q3 FY202522.5derived
Q2 FY202522.5derived
Q1 FY202522.7reported
Q4 FY202422.9derived
Q3 FY202426.8derived
Q2 FY202428.0derived
Q1 FY202429.3reported
Q4 FY202329.5derived
Q3 FY202328.4derived
Q2 FY202327.3derived
Q1 FY202327.5reported
Q4 FY202227.2derived
Q3 FY202228.6derived
Q2 FY202229.5derived
Q1 FY202230.3reported
Q4 FY202130.4derived
Q3 FY202128.8derived
Q2 FY202128.5derived
Q1 FY202127.7reported
Q4 FY202026.5derived
Q3 FY202026.2derived
Q2 FY202024.1derived
Q1 FY202019.0reported
Q4 FY201921.9derived
Q3 FY201918.4derived
Q2 FY201914.2derived
Q1 FY201914.0reported
Q4 FY201815.4derived
Q3 FY201814.0derived
Q2 FY201814.9derived
Q1 FY201815.2reported
Q4 FY201715.5derived
Q3 FY201715.3derived
Q2 FY201715.4derived
Q1 FY201714.9reported
Q4 FY201614.5derived
Q3 FY201614.4derived
Q2 FY201614.1derived
Q1 FY201613.8reported

CSV with all sources · Technical ID: dna

More metrics for F5

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Sources & calculation
Value
$30.0M (derived)
Period
Q2 FY2022, ended Mar 31, 2022 · quarterly value (3 months, not cumulative)
Calculation
Q2 = 6 months kumuliert − 3 months kumuliert = 60M − 30M = $30.0M (us-gaap:DepreciationDepletionAndAmortization; 6-Monats-Wert aus 0001048695-23-000018, Vorperiode aus dem vorherigen 10-Q)
Source
10-Q, filed May 5, 2023 · 0001048695-23-000018
Location
us-gaap:DepreciationDepletionAndAmortization
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$30.0MMay 5, 202310-Q 0001048695-23-000018derived · confidence 1. · current